Abnormal prothrombin (PIVKA-II) and hepatocellular carcinoma.
Okuda
H
H
Institute of Gastroenterology, Tokyo Women's Medical College, Japan.
Nakanish
T
T
Furukawa
M
M
Yamagata
H
H
Obata
H
H
D015415:Biomarkers; D014408:Biomarkers, Tumor / Q000097:blood*; D006528:Carcinoma, Hepatocellular / Q000097:blood* / Q000188:drug therapy; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006801:Humans; D008107:Liver Diseases / Q000097:blood; D008113:Liver Neoplasms / Q000097:blood* / Q000188:drug therapy; D008297:Male; D011247:Pregnancy; D011498:Protein Precursors / Q000032:analysis*; D011516:Prothrombin / Q000032:analysis*; D014407:Tumor Cells, Cultured; D014812:Vitamin K / Q000627:therapeutic use; D000509:alpha-Fetoproteins / Q000032:analysis
D015415:Biomarkers; D014408:Biomarkers, Tumor; D011498:Protein Precursors; D000509:alpha-Fetoproteins; D014812:Vitamin K; C008208:acarboxyprothrombin; D011516:Prothrombin